Detalhe da pesquisa
1.
TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment.
Prostate
; 84(1): 87-99, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37812042
2.
Genomic biomarkers to guide precision radiotherapy in prostate cancer.
Prostate
; 82 Suppl 1: S73-S85, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35657158
3.
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
World J Urol
; 37(12): 2557-2564, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30578441
4.
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.
Nat Cancer
; 5(1): 114-130, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38177459
5.
Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer.
Eur Urol Oncol
; 2024 Jun 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38862340
6.
Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer.
Cancer Res
; 83(17): 2970-2984, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37352385
7.
Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer.
Eur Urol
; 84(6): 531-535, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37173210
8.
WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 115(5): 1095-1101, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36708787
9.
Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer.
JCO Precis Oncol
; 6: e2100543, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35507889
10.
Shallow whole-genome sequencing: a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue-a glioma-driven study.
Virchows Arch
; 480(3): 677-686, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35034191
11.
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics.
Prostate Cancer Prostatic Dis
; 25(4): 713-719, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35013522
12.
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.
J Clin Oncol
; 40(29): 3377-3382, 2022 10 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36001857
13.
Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review.
Eur Urol Oncol
; 4(6): 914-923, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34801437
14.
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited.
Eur Urol
; 80(5): 632-640, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33419682
15.
Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine.
Eur Urol Open Sci
; 30: 47-62, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34337548
16.
Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma.
Genome Med
; 12(1): 35, 2020 04 21.
Artigo
Inglês
| MEDLINE | ID: mdl-32317009
17.
Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples.
BMC Med Genomics
; 13(1): 94, 2020 07 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32631411
18.
Oligometastatic prostate cancer: The game is afoot.
Cancer Treat Rev
; 73: 84-90, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30684842
19.
Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma.
Eur Urol
; 75(5): 707-711, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30665814